TUMOUR NECROSIS FACTOR a EXPRESSION IN TUMOUR ISLETS CONFERS A SURVIVAL ADVANTAGE IN NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Ohri, C. M. [1 ]
Shikotra, A. [1 ]
Green, R. H. [1 ]
Waller, D. A. [1 ]
Bradding, P. [1 ]
机构：
[1] Glenfield Hosp, Inst Lung Hlth, Leicester, Leics, England
来源：
THORAX | 2009年 / 64卷
关键词：
D O I：
10.1136/thx.2009.127092p
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [31] Clinical significance of disseminated tumour cells in non-small cell lung cancer
    Rud, A. K.
    Borgen, E.
    Maelandsmo, G. M.
    Flatmark, K.
    Le, H.
    Josefsen, D.
    Solvoll, I.
    Schirmer, C. B.
    Helland, A.
    Jorgensen, L.
    Brustugun, O. T.
    Fodstad, O.
    Boye, K.
    BRITISH JOURNAL OF CANCER, 2013, 109 (05) : 1264 - 1270
  • [32] Transesophageal Ultrasound and the Assessment of Tumour Invasion in Non-Small Cell Lung Cancer
    Annema, Jouke T.
    Versteegh, Michel M.
    Veselic, Maud
    Rabe, Klaus F.
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB259 - AB259
  • [33] Dependence of fluorodeoxyglucose avidity on tumour size in non-small cell lung cancer
    Ding, P.
    Tai, J.
    Manders, P.
    Stone, E.
    Ho, B.
    Epstein, R.
    ANNALS OF ONCOLOGY, 2015, 26 : 153 - 154
  • [34] The significance of tumour markers as an indication for mediastinoscopy in non-small cell lung cancer
    Ando, S
    Kimura, H
    Iwai, N
    Kakizawa, K
    Shima, M
    Ando, M
    RESPIROLOGY, 2003, 8 (02) : 163 - 167
  • [35] Spatially mapping the tumour immune microenvironments of non-small cell lung cancer
    Desharnais, Lysanne
    Sorin, Mark
    Rezanejad, Morteza
    Liu, Bridget
    Karimi, Elham
    Atallah, Aline
    Swaby, Anikka M.
    Yu, Miranda W.
    Dore, Samuel
    Hartner, Saskia
    Fiset, Benoit
    Wei, Yuhong
    Kadang, Baharak
    Rayes, Roni
    Joubert, Philippe
    Camilleri-Broet, Sophie
    Fiset, Pierre-Olivier
    Quail, Daniela F.
    Spicer, Jonathan D.
    Walsh, Logan A.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [36] DETECTION OF CIRCULATING TUMOUR CELLS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Fanning, Michael
    Lehman, Margot
    Mai, Tao
    Horwood, Keith
    Murphy, Michelle
    Mccafferey, Elizabeth
    Jovanovic, Lidija
    Upham, John
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S477 - S477
  • [37] Evaluation of different markers in non-small cell lung cancer: Prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival
    Kasimir-Bauer, S
    Schleucher, N
    Weber, R
    Neumann, R
    Seeber, S
    ONCOLOGY REPORTS, 2003, 10 (02) : 475 - 482
  • [38] Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
    Xu, Yan
    Li, Ji
    Tong, Bing
    Chen, Minjiang
    Liu, Xiaoyan
    Zhong, Wei
    Zhao, Jing
    Wang, Mengzhao
    ESMO OPEN, 2020, 5 (04) : 1 - 11
  • [39] PD-L1 expression in primary tumour and circulating tumour cells in patients with advanced non-small cell lung cancer
    Ilie, M.
    Szafer-Glusman, E.
    Hofman, V.
    Long, E.
    Lalvee, S.
    Selva, E.
    Marquette, C. H.
    Kowanetz, M.
    Hedge, P.
    Punnoose, K.
    Hofman, P.
    VIRCHOWS ARCHIV, 2016, 469 : S36 - S36
  • [40] Influence of Tumour Location and Histological Sub-Type of Non-Small Cell Lung Cancer on Patient Survival
    McWilliam, A.
    Davey, A.
    Osorio, E. Vasquez
    Aznar, M.
    Faivre-Finn, C.
    Van Herk, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S833 - S834
12345